Back to Search
Start Over
Periarticular injection of liposomal bupivacaine in total knee arthroplasty.
- Source :
-
Arthroplasty today [Arthroplast Today] 2015 Oct 12; Vol. 1 (4), pp. 117-120. Date of Electronic Publication: 2015 Oct 12 (Print Publication: 2015). - Publication Year :
- 2015
-
Abstract
- The purpose of this study was to determine whether the use of a periarticular injection using liposomal bupivacaine could decrease pain and improve outcomes after total knee arthroplasty. Fifty consecutive patients received no periarticular injections (group A). Another 50 consecutive patients received a periarticular injection of liposomal bupivacaine (group B). There were no differences in the groups with respect to gender, age, body mass index (BMI), or comorbidities. There was a significant reduction in the amount of narcotics used in the liposomal bupivacaine group (60.97-mg oral morphine equivalent vs 89.74 mg, P  = 0.009). Patients in group B with a BMI <40 and a Charlson comorbidity index of 0-3 had decreased length of stay (2.64 vs 3.06 days, P  = .004), narcotic use over 24-48 hours (110.66 vs 182.47 mg, P  = .013), and narcotic use over 48-72 hours (49.61 vs. 112.65 mg, P  = .004). In patients with a BMI <40 and comorbidity index of ≤3, periarticular injection using liposomal bupivacaine leads to earlier discharge along with decreased use of narcotics.
Details
- Language :
- English
- ISSN :
- 2352-3441
- Volume :
- 1
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Arthroplasty today
- Publication Type :
- Academic Journal
- Accession number :
- 28326386
- Full Text :
- https://doi.org/10.1016/j.artd.2015.09.001